Expert: FDA’s Highly Anticipated PCCP Guidance Isn’t Anything Too ‘Surprising’
The FDA’s highly anticipated predetermined chance control plan (PCCP) guidance document is pretty much what the industry expected, Sidley Austin partner Deeona Gaskin told Medtech Insight.
